UBS AM’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-38,928
| Closed | -$3.11M | – | 2802 |
|
|
2021
Q1 | $3.11M | Sell |
38,928
-3,383
| -8% | -$264K | ﹤0.01% | 1561 |
|
|
2020
Q4 | $3.34M | Sell |
42,311
-3,715
| -8% | -$218K | ﹤0.01% | 1464 |
|
|
2020
Q3 | $2.02M | Sell |
46,026
-595
| -1% | -$29.3K | ﹤0.01% | 1540 |
|
|
2020
Q2 | $2.06M | Sell |
46,621
-10,240
| -18% | -$382K | ﹤0.01% | 1507 |
|
|
2020
Q1 | $2.04M | Buy |
56,861
+4,895
| +9% | +$278K | ﹤0.01% | 1398 |
|
|
2019
Q4 | $3.68M | Buy |
51,966
+3,585
| +7% | +$260K | ﹤0.01% | 1326 |
|
|
2019
Q3 | $3.62M | Buy |
48,381
+1,887
| +4% | +$160K | ﹤0.01% | 1340 |
|
|
2019
Q2 | $3.75M | Buy |
46,494
+3,713
| +9% | +$261K | ﹤0.01% | 1304 |
|
|
2019
Q1 | $2.86M | Buy |
42,781
+8,625
| +25% | +$653K | ﹤0.01% | 1360 |
|
|
2018
Q4 | $2.54M | Sell |
34,156
-1,727
| -5% | -$143K | ﹤0.01% | 1333 |
|
|
2018
Q3 | $3.3M | Buy |
35,883
+394
| +1% | +$37.5K | ﹤0.01% | 1294 |
|
|
2018
Q2 | $3.49M | Buy |
35,489
+11,774
| +50% | +$1.32M | ﹤0.01% | 1280 |
|
|
2018
Q1 | $2.64M | Buy |
23,715
+903
| +4% | +$101K | ﹤0.01% | 1356 |
|
|
2017
Q4 | $2.35M | Buy |
22,812
+809
| +4% | +$80.6K | ﹤0.01% | 1363 |
|
|
2017
Q3 | $2.07M | Buy |
22,003
+854
| +4% | +$67.4K | ﹤0.01% | 1389 |
|
|
2017
Q2 | $1.65M | Buy |
21,149
+752
| +4% | +$56.5K | ﹤0.01% | 1437 |
|
|
2017
Q1 | $1.63M | Buy |
20,397
+3,311
| +19% | +$263K | ﹤0.01% | 1434 |
|
|
2016
Q4 | $1.34M | Sell |
17,086
-8,850
| -34% | -$688K | ﹤0.01% | 1447 |
|
|
2016
Q3 | $2.02M | Buy |
25,936
+2,837
| +12% | +$206K | ﹤0.01% | 1371 |
|
|
2016
Q2 | $1.59M | Buy |
23,099
+163
| +0.7% | +$11.2K | ﹤0.01% | 1442 |
|
|
2016
Q1 | $1.64M | Sell |
22,936
-2,353
| -9% | -$148K | ﹤0.01% | 1439 |
|
|
2015
Q4 | $1.57M | Buy |
25,289
+9,019
| +55% | +$550K | ﹤0.01% | 1553 |
|
|
2015
Q3 | $923K | Buy |
16,270
+420
| +3% | +$22.2K | ﹤0.01% | 1754 |
|
|
2015
Q2 | $851K | Buy |
15,850
+1,500
| +10% | +$73K | ﹤0.01% | 1758 |
|
|
2015
Q1 | $682K | Buy |
14,350
+800
| +6% | +$35.4K | ﹤0.01% | 1805 |
|
|
2014
Q4 | $586K | Buy |
13,550
+900
| +7% | +$36.8K | ﹤0.01% | 1858 |
|
|
2014
Q3 | $435K | Hold |
12,650
| – | – | ﹤0.01% | 1954 |
|
|
2014
Q2 | $463K | Hold |
12,650
| – | – | ﹤0.01% | 1941 |
|
|
2014
Q1 | $427K | Hold |
12,650
| – | – | ﹤0.01% | 1974 |
|
|
2013
Q4 | $429K | Sell |
12,650
-400
| -3% | -$13.9K | ﹤0.01% | 1893 |
|
|
2013
Q3 | $416K | Hold |
13,050
| – | – | ﹤0.01% | 1876 |
|
|
2013
Q2 | $295K | Buy |
+13,050
| New | +$283K | ﹤0.01% | 2002 |
|
UBS AM's CMD Position: Q2 2021 in Review
UBS AM sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 38,928 shares — an estimated $3.11M sold.
UBS AM first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $3.75M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- UBS AM reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- UBS AM sold 38,928 Cantel Medical Corporation shares in Q2 2021, an estimated $3.11M.
- UBS AM first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- UBS AM's Cantel Medical Corporation position peaked at $3.75M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.